Cowen raised the firm’s price target on Bath & Body Works to $52 from $45 and keeps an Outperform rating on the shares. The firm, which maintains its Q4 estimates above consensus and "slightly" lowered its Q1 and FY23 estimates to be in line with the Street, continues to believe Bath & Body’s growth algorithm should "merit at least a mid-teens multiple."
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BBWI:
- Bath & Body Works to Report Fourth Quarter and Fiscal 2022 Financial Results on February 23, 2023
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Citi downgrades Bath & Body on risk of margin ‘reset’
- Bath & Body Works downgraded to Neutral from Buy at Citi
- Third Point buys AIG, exits T-Mobile in Q4
